Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis,
Gainers
Statera BioPharma (NASDAQ:STAB) shares increased by 33.1% to $0.2 during Friday's pre-market session. The company's market cap stands at $10.4 million.
Statera Biopharma Inc (NASDAQ:STAB) signed a binding Memorandum of Understanding with Holobeam Technologies Inc. Holobeam offers holographic medical imaging and therapeutic technologies…